Shingles News
Recent news reports about shingles in Canada
March 2026
National Institute on Ageing new vaccine resource
Toronto, ON - The NIA’s new Provincial and Territorial Vaccine One-Pagers for Adults 65+ (2025/26) make it simple to learn which vaccines are nationally recommended, which vaccines are free, where to get vaccines and you can also learn what’s covered in your province or territory. For more information or to download these one-pagers: https://niageing.ca/provincial-territorial-vaccines
February 2026
National Institute on Ageing releases new shingles report
Toronto, ON - As Canada marks National Shingles Awareness Week, the National Institute on Ageing (NIA) released a new report warning that shingles remains a largely overlooked yet preventable health risk for older Canadians. Shingles infections continue to cause unnecessary pain and long-term complications for individuals and avoidable strain on Canada’s health care system.
Canada’s National Advisory Committee on Immunization (NACI) strongly recommends the recombinant zoster vaccine for adults aged 50 and older, as well as immunocompromised adults aged 18 and older. Despite this recommendation, fewer than four in ten Canadians aged 50 and older have received even a single dose of the shingles vaccine. The new report, The Overlooked Issue of Shingles Infections in Older Canadians and How to Address It, estimates that approximately 130,000 new shingles cases occur in Canada each year. The report also estimates an annual health system impact of approximately $67–82 million, driven primarily by the prevalence of shingles among adults aged 60 and older and its associated complications.
To download: The Overlooked Issue of Shingles Infections in Older Canadians and How to Address It. (2026)
December 2025
CBoC publishes report on benefits of shingles immunization programs
Toronto, ON - The Conference Board of Canada (CBoC) has recently released an engaging infographic titled “Guarding Health, Driving Productivity,” which underscores the extensive economic benefits of investing in shingles (herpes zoster) immunization programs. This informative infographic was recently unveiled at the Toronto Board of Trade and offers a sneak peek into a comprehensive report set to be published in Q1 2026. The CBoC analysis enhances previous reports on the patient and health-system benefits of this immunization program and introduces a compelling economic perspective.
According to the analysis, investing in shingles immunization programs can drive significant productivity and economic growth. One of the headline findings reveals that every dollar invested in shingles immunization yields approximately $1.69 in economic benefits. The report quantifies the avoided work-loss days and related wage impacts, comparing the returns of the shingles program with other public health investments. For context, workplace mental health programs are estimated to return around $1.62, and public cardiovascular research returns about $1.21.Other notable findings reveal that coast-to-coast coverage of Shingrix for adults aged 50+ could generate up to $306 million in additional tax revenue.
The infographic provides regional and provincial breakdowns as well as patient and target-group details, which will be invaluable for tailored outreach to provincial decision-makers and local coalitions.
For more information: https://www.conferenceboard.ca/wp-content/uploads/2022/10/guarding-health-driving-productivity_2025.pdf
